SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a sharp decline as investors respond to an underwhelming WWDC presentation, with many community members questioning the company's innovation and its heavy reliance on third-party AI models. While some long-term investors see the pullback as a buying opportunity, others are aggressively rotating into bearish positions, citing the stock's elevated valuation and the lack of a clear, immediate revenue catalyst from the new AI features.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 ETF is seeing extreme volatility as market sentiment shifts rapidly between optimism over a potential Iran ceasefire deal and intense liquidity concerns surrounding the upcoming SpaceX IPO. Investors are actively debating the sustainability of current price levels, with many traders cautioning against complacency while others aggressively play both sides of the sharp intraday swings.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 is experiencing significant volatility as market participants debate the impact of high-interest rates on small-cap balance sheets versus the potential for a rotation out of overextended large-cap AI stocks. Community sentiment is deeply divided between traders capitalizing on rapid price swings and those expressing concern over a disconnect between current valuations and underlying economic data like persistent inflation and labor market figures.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is seeing intense trading activity as investors closely monitor demand for the R2 SUV and its upcoming public deliveries. The community remains deeply divided, with bulls highlighting technological growth and potential new partnerships, while bears continue to focus on the company's long-term path to profitability and high volatility.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following the announcement of a new $5.2 billion, 15-year AI data center lease at its fifth campus, an event that has spurred bullish analyst upgrades and renewed investor confidence. The community is actively debating the stock's significant contracted revenue backlog against broader market volatility and algorithmic trading patterns, with many long-term holders viewing current price fluctuations as accumulation opportunities ahead of a potential re-rating.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending as investors speculate on a potential hyperscaler partnership, fueled by an Amazon job posting for a facility in the company's development region. The community remains highly focused on upcoming contract announcements and technical price action, viewing recent volatility as a consolidation phase before potential further upside.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as investors weigh a wave of high-profile AI-related IPOs against broader market concerns regarding inflation and geopolitical uncertainty. The community is actively debating whether current price action represents a healthy consolidation or a warning sign of a potential liquidity crunch as capital rotates in anticipation of upcoming mega-cap public debuts.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors weigh the potential impact of a legal dispute with Nippon Shinyaku against the upcoming PDUFA catalyst for Deramiocel. The community remains largely bullish, focusing on institutional accumulation and the potential for a favorable court resolution to allow for independent commercialization.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors anticipate the upcoming earnings report and potential catalysts, including a patent extension for MIPLYFFA and European market expansion. The community is actively discussing the stock's long-term valuation, the strategic significance of recent institutional buying, and the potential for a buyout, while maintaining a watchful eye on technical levels.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors digest preliminary May data showing significant double-digit month-over-month growth in its Predictions platform volume. While some community members remain skeptical due to the stock's long-term performance and management's share selling, others are actively debating whether these prediction markets and upcoming major sporting events provide a necessary catalyst for a sustainable breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biote Appoints Komal Bajaj As CMO

(RTTNews) - Biote Corp. (BTMD), a medical practice-building company, on Monday announced the appointment of Komal Bajaj as Chief Medical Officer, effective June 1...

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Corp. (NASDAQ: BTMD) (Biote or the Company) today announced the appointment of Komal Bajaj, MD, MS, as Chief Medical Officer, effective June 1, 2026. Dr. Bajaj is a nationally recognized physician executive, board-certified OB/GYN and reproductive geneticist with more than two decades of...

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners patients, today announced that Bob Peterson, Chief Financial Officer and Chief Business Officer, has been named Interim Chief Executive Officer and...

biote (NASDAQ:BTMD) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS

biote (NASDAQ:BTMD - Get Free Report) posted its earnings results on Wednesday. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by...

Biote (BTMD) Q1 2026 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

biote Corp. (BTMD) delivered earnings and revenue surprises of -33.33% and -2.71%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Biote Q1 2026 Earnings Call: Complete Transcript

Biote Reports First Quarter 2026 Financial Results

Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners patients, today announced financial results for the...

GE HealthCare Technologies (GEHC) Lags Q1 Earnings Estimates

GE HealthCare (GEHC) delivered earnings and revenue surprises of -7.04% and +1.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

biote (BTMD) Expected to Announce Quarterly Earnings on Wednesday

biote (NASDAQ:BTMD) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-haymaker-acquisition-corp-iii-stock...

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.02	--	--	N/A
Q1 '26	$0.05	$0.06	26.32%	BEAT
Q4 '25	$0.04	$0.06	50.00%	BEAT
Q3 '25	$0.08	$0.22	183.87%	BEAT
Q2 '25	$0.08	$0.10	25.00%	BEAT

BTMDbiote Corp

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest BTMD News